Suketu Upadhyay - Endo International CFO and Executive VP

CFO

Mr. Suketu P. Upadhyay is no longer Executive Vice President and Chief Financial Officer of Endo International Public Limited Company effective November 22 2016. Prior to joining Endo since 2010 Mr. Upadhyay served as Interim Chief Financial Officer as well as Senior Vice President of Finance and Corporationrationrate Controller of Becton Dickinson Co . In addition to other executive finance roles at BD from 2007 to 2010 he served in various finance leadership roles at AstraZeneca and Johnson Johnson since 2013.
Age 45
Tenure 11 years
Professional MarksCPA
Phone353 1 268 2000
Webhttps://www.endo.com
Upadhyay spent the early part of his career in public accounting with KPMG and received his CPA in May 1996.

Endo International Management Efficiency

The company has return on total asset (ROA) of 5.11 % which means that it generated a profit of $5.11 on every $100 spent on assets. This is normal as compared to the sector avarege. Endo International's management efficiency ratios could be used to measure how well Endo International manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 8.13 B in liabilities with Debt to Equity (D/E) ratio of 1.98, which is about average as compared to similar companies. Endo International PLC has a current ratio of 1.77, which is within standard range for the sector. Debt can assist Endo International until it has trouble settling it off, either with new capital or with free cash flow. So, Endo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endo International PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endo to invest in growth at high rates of return. When we think about Endo International's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CFO Age

Michael GoergenDigi International
49
Christine GorjancNETGEAR
60
Gina MastantuonoServiceNow
54
Michael ScarpelliServiceNow
51
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Endo International operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NMS Exchange. It employs 3103 people. Endo International PLC (ENDP) is traded on NASDAQ Exchange in USA and employs 3,103 people.

Management Performance

Endo International PLC Leadership Team

Elected by the shareholders, the Endo International's board of directors comprises two types of representatives: Endo International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endo. The board's role is to monitor Endo International's management team and ensure that shareholders' interests are well served. Endo International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endo International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carrie Nichol, Chief Accounting Officer, Vice President Controller
William Spengler, Director
Arthur Higgins, Independent Director
Brian Lortie, President U.S. Branded Pharmaceuticals
Donald DeGolyer, Special Advisor to the CEO
William Montague, Director
Michael Hyatt, Director
Douglas Ingram, Director
Antonio Pera, President - Par Pharmaceutical
Domenic Ciarico, Executive Vice President Chief Commercial Officer - Sterile and Generics
Roger Kimmel, Chairman of the Board
Susan Hall, Chief Scientific Officer, Global Head of RandD and Quality and Executive VP
Sharad Mansukani, Director
Suketu Upadhyay, CFO and Executive VP
Nancy Hutson, Independent Director
Todd Sisitsky, Director
Patrick Barry, Executive Vice President and Chief Commercial Officer
Shane Cooke, Independent Director
Craig Paterson, Chief Medical Officer
Daniel Rudio, Senior Vice President Chief Accounting Officer, Controller
Camille Farhat, President of American Medical Systems, Inc
Paul Campanelli, President CEO, Director
Jill Smith, Director
Rajiv Silva, CEO and President and Director
Nina Goworek, Senior Director, Investor Relations
Blaise Coleman, Senior Vice President of Global Finance Operations and Interim CFO
Terrance Coughlin, COO, Executive Vice President
Matthew Maletta, Executive Vice President Chief Legal Officer

Endo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endo International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Endo International in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Endo International's short interest history, or implied volatility extrapolated from Endo International options trading.

Pair Trading with Endo International

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endo International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endo International will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Dentsply Sirona could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dentsply Sirona when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dentsply Sirona - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dentsply Sirona to buy it.
The correlation of Dentsply Sirona is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dentsply Sirona moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dentsply Sirona moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dentsply Sirona can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Endo International PLC information on this page should be used as a complementary analysis to other Endo International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Endo Stock

If you are still planning to invest in Endo International PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Endo International's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios